Author

S. E. Farley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

C. Schultz· 2 shared F. G. Tafesse· 2 shared T. A. Bates· 2 shared F. Stein· 1 shared F. Tafesse· 1 shared H. C. Leier· 1 shared H. Leier· 1 shared J. B. Weinstein· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

C. Schultz

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Trifunctional sphinganine: a new tool to dissect sphingolipid function

S. E. Farley, F. Stein, P. Haberkant, F. G. Tafesse, C. Schultz

The paper develops multifunctional derivatives of sphingosine and sphinganine to study their cellular roles, revealing distinct protein interactomes and spatiotemporal distributions.

bioRxiv · Oct 16, 2023Biochemistry

A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants

S. E. Farley, J. Kyle, H. Leier, L. M. Bramer, J. Weinstein, T. A. Bates, J.-Y. Lee, T. O. Metz, C. Schultz, F. Tafesse

The paper identifies glycerolipid biosynthesis as a conserved host dependency factor for SARS-CoV-2 by mapping lipid metabolism changes across variants.

bioRxiv · Feb 14, 2022Microbiology

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2

T. A. Bates, J. B. Weinstein, S. E. Farley, H. C. Leier, W. B. Messer, F. G. Tafesse

This study evaluates cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 and finds a high proportion of tested antibodies show cross-reactivity, suggesting potential utility in research and therapeutic development.

bioRxiv · Jul 30, 2020Immunology